Branding and study outputs
We encourage you to use the NIHR logotype, where permitted. You can also use your own project logo on outputs. You can find out how to do this in our identity guidelines.
If your project is part of the MRC Clinical Trials portfolio, special arrangements apply (please contact EME to find out more).
It is a contractual requirement that you provide notifications and copies of all of your project outputs at least 28 days before publication or presentation. We can assist with naming of the NIHR and our funding or other support. See also our open access policy.
What is an output?
An output is any item arising from NIHR-funded research that enters the public domain. Outputs can be written, audio/visual, electronic or verbally presented. The NIHR takes a broad definition of what constitutes an output. These might include but are not limited to:
- written outputs such as press releases, research reports, journal articles, abstracts, presentation slides, posters, websites, books or book chapters, blogs and other forms of social media, newsletters
- presentations, speaking at events or in the media including media interviews
- training materials such as manuals or DVDs
- checklists, scales, protocols, questionnaires, toolkits
- service guidelines or similar
- service innovations or new service delivery models
- research tools such as data analysis techniques, assays, cell lines, antibodies, biomarkers
- patentable inventions such as new therapeutic products, equipment, diagnostic test or medical devices
- participant materials.
If you are not sure whether something qualifies as an output, please get in touch with your programme.
Detailed information is included in the NIHR identity guidelines, particularly Chapters 10 and 14.
Programme outputs from EME / HS&DR / PHR / HTA
To submit an output notification for EME/HS&DR/PHR/HTA, please use the button below to login to the NETSCC MIS and follow the instructions in the quick reference guide.
Please keep us updated about the progress of your output (e.g. from submission to acceptance/rejection or acceptance to publication) by updating the MIS or if you do not have access to the MIS by emailing us at the following address:
Programme outputs from i4i / PGfAR / RfPB
To submit an output notification for i4i/PGfAR/RfPB, or to keep us updated regarding progress of your output, please email the details/attachments to your Programme Manager:
Acknowledgements and disclaimers
We must be acknowledged as the funder of your research in both oral and written outputs.
All published material must contain an acknowledgement of funding, and when mentioning research findings or opinions, an appropriate disclaimer. We may ask you to add/edit an acknowledgement and/or disclaimer if necessary, but do not approve your outputs. Please also acknowledge any other NIHR support the study may have received such as through our Clinical Research Network or a Clinical Research Facility or Biomedical Research Centre.
|All Programmes (except EME - see below)|
This project [or study or research] was funded by the NIHR [name programme] (project number or ref xx/xx/xx)
Department of Health disclaimer
The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
As EME is jointly funded by the MRC and the NIHR, EME research projects must instead use the following:
*The EME Programme is funded by the MRC and NIHR, with contributions from the CSO in Scotland and NISCHR in Wales and the HSC R&D Division, Public Health Agency in Northern Ireland.
NIHR Dissemination Centre – Right Evidence, Better Decisions
The NIHR Dissemination Centre summarises research funded by the NIHR and others, and shares the findings with an engaged audience of clinicians, commissioners and patients.